Corbus Pharmaceuticals Holdings (CRBP) Net Income towards Common Stockholders (QoQ) (2013 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) Net Income towards Common Stockholders (QoQ) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 112.73 Mn | 84.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1,958.22% |
| Jun 30, 2025 | 196.69% |
| Mar 31, 2025 | -173.38% |
| Dec 31, 2024 | 110.23% |
| Sep 30, 2024 | 21.83% |
| Jun 30, 2024 | -12,353.97% |
| Mar 31, 2024 | 101.76% |
| Dec 31, 2023 | 64.61% |
| Sep 30, 2023 | -4.66% |
| Jun 30, 2023 | -58.82% |
| Mar 31, 2023 | -72.45% |
| Dec 31, 2022 | 44.82% |
| Sep 30, 2022 | 17.27% |
| Jun 30, 2022 | -151.74% |
| Mar 31, 2022 | 11.81% |
| Dec 31, 2021 | 80.19% |
| Sep 30, 2021 | 2.38% |
| Jun 30, 2021 | -4.27% |
| Mar 31, 2021 | -146.67% |
| Dec 31, 2020 | 69.21% |